Benralizumab beneficial for eosinophilic exacerbations of asthma, chronic obstructive ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Too Old to Operate1 小时
Benralizumab Beneficial for Eosinophilic Exacerbations of Asthma, COPD
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Pharmabiz3 小时
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...
Daily1 小时
USFDA accepts GSK submission for use of Nucala in COPD
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study ...
FDA to review GSK’s Nucala for COPD
The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...
Medscape21 小时
More Biologics May Be Breaking Through for COPD
Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...